Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Immune dysfunction in cirrhosis Sipeki N; Antal-Szalmas P; Lakatos PL; Papp MWorld J Gastroenterol 2014[Mar]; 20 (10): 2564-77Innate and adaptive immune dysfunction, also referred to as cirrhosis-associated immune dysfunction syndrome, is a major component of cirrhosis, and plays a pivotal role in the pathogenesis of both the acute and chronic worsening of liver function. During the evolution of the disease, acute decompensation events associated with organ failure(s), so-called acute-on chronic liver failure, and chronic decompensation with progression of liver fibrosis and also development of disease specific complications, comprise distinct clinical entities with different immunopathology mechanisms. Enhanced bacterial translocation associated with systemic endotoxemia and increased occurrence of systemic bacterial infections have substantial impacts on both clinical situations. Acute and chronic exposure to bacteria and/or their products, however, can result in variable clinical consequences. The immune status of patients is not constant during the illness; consequently, alterations of the balance between pro- and anti-inflammatory processes result in very different dynamic courses. In this review we give a detailed overview of acquired immune dysfunction and its consequences for cirrhosis. We demonstrate the substantial influence of inherited innate immune dysfunction on acute and chronic inflammatory processes in cirrhosis caused by the pre-existing acquired immune dysfunction with limited compensatory mechanisms. Moreover, we highlight the current facts and future perspectives of how the assessment of immune dysfunction can assist clinicians in everyday practical decision-making when establishing treatment and care strategies for the patients with end-stage liver disease. Early and efficient recognition of inappropriate performance of the immune system is essential for overcoming complications, delaying progression and reducing mortality.|*Adaptive Immunity[MESH]|*Immunity, Innate[MESH]|Animals[MESH]|Bacterial Infections/*immunology/microbiology/mortality[MESH]|Complement System Proteins/metabolism[MESH]|Disease Progression[MESH]|End Stage Liver Disease/*immunology/mortality[MESH]|Humans[MESH]|Inflammation Mediators/metabolism[MESH]|Liver Cirrhosis/complications/diagnosis/*immunology/metabolism/mortality[MESH]|Liver Failure, Acute/*immunology/mortality[MESH]|Macrophages/immunology[MESH]|Monocytes/immunology[MESH]|Neutrophils/immunology[MESH]|Prognosis[MESH]|Risk Factors[MESH]|Signal Transduction[MESH] |
